This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Caliper Life Sciences expects sales to the academic sector to continue increasing in 2007 as the benefits from its acquisition of Xenogen last year and the launch of several new products gain momentum, company officials said last week.
 
The firm also expects OEM sales of its chips to Agilent and liquid-handling equipment to Affymetrix will pick up in 2007 after a drop-off in 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.